Clinical Research and Treatment of
Interstitial Cystitis/ Bladder Pain Syndrome

IC Study

Clinical Research to Help Patients with Interstitial Cystitis


Interstitial Cystitis Clinical Research

Posted by on January 23, 2016 at 7:00 PM



I have received FDA approval for all my IC studies and am presently the principal investigator in three research studies available for the treatment of interstitial cystitis. One is with Dr. Parsons from UCSD on a better bladder instillation treatment. The next is a study on the benefits of patient counseling and an FDA approved medicine that treats autoimmune diseases. This is the certolizumab pegol study and is the most promising. The last is a study with Allergan on a device (LiRis) I put in the bladder that may release a long acting numbing medicine to relieve the symptoms of IC.


The bladder instillation study is a one time 2 day study that patients have done well with.


The advantages of the certolizumab study is that the medicine could take away your symptoms of IC. There is a 66% chance you get certolizumab pegol and a 33% chance you get placebo. I have already started recruiting patients. you would need to be out to southern California for 3 days to check your lab work and receive the first injection, 2 weeks and 4 weeks later there is another injection, and a final injection 4 weeks after that.


Looking forward to hearing from you.


Dr. Bosch

Categories: None

Post a Comment


Oops, you forgot something.


The words you entered did not match the given text. Please try again.

Already a member? Sign In